Explore our review on the increasing burden, deepening inequality and effective prevention initiatives.
Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X: … Read More
Mar 06, 2026
Ieva Ailte, PhD, Project manager EUnetCCC at Oslo University Hospital shared a post on LinkedIn: “Members of EUnetCCC Task for Cancer Research are gathering at The Netherlands Cancer Institute (NKI) … Read More
Mar 06, 2026
Hung Trinh, Senior VP of Operations at Seneca Therapeutics and CMC/MFG Consultant and Managing Director at Vertex Biopharm Consulting, shared a post on LinkedIn: “Moderna to pay up to $2.25B to end … Read More
Mar 06, 2026
Soumen Das, Head of Department of Surgical Oncology at Netaji Subhas Chandra Bose Cancer Hospital, CEO and Co-Founder at ArrowsUP LLP, and Co-Founder at Specifixon Healthcare, shared a post on LinkedIn: … Read More
Mar 06, 2026
Esther Krofah, Executive Vice President at Milken Institute Health shared a post on LinkedIn: “It was a privilege to convene Cancer 2035: A Roadmap for the Future, as a partnership … Read More
Mar 06, 2026
Marty Makary, Commissioner of the U.S. Food and Drug Administration (FDA), shared a post on X: “FDA is moving with unprecedented agility. Today we approved a multiple myeloma drug just 55 … Read More
Mar 06, 2026
For muscle-invasive bladder cancer (MIBC), the standard approach is radical cystectomy plus cisplatin-based neoadjuvant chemotherapy. However, ~50% of patients are ineligible for cisplatin or choose to decline it. Both pembrolizumab … Read More
Mar 06, 2026
Dana Alattar, Research Volunteer at King Hussein Cancer Foundation and Center and Tutor at Socrates Academy, shared a post on LinkedIn: “New Publication Is caffeine truly a cardiovascular protective agent, or … Read More
Mar 06, 2026
Gonzalo López-Cuevas, Founding President of Cancer Warriors of Mexico, Treasurer at Union for International Cancer Control (UICC), shared a post on LinkedIn: “Vision takes shape. I am pleased to share my personal … Read More
Mar 06, 2026
Iylon Precision Oncology shared a post in LinkedIn: “Precision Oncology with Radioimmunotherapy for Peritoneal Carcinomatosis In this paper ‘Radioimmunotherapy for peritoneal carcinomatosis: Preclinical proof of concept to clinical translation’, Dr. Nicole … Read More
Mar 06, 2026